LON:UPR Uniphar (UPR) Share Price, News & Analysis GBX 228.75 -3.25 (-1.40%) As of 11:40 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesBuy This Stock About Uniphar Stock (LON:UPR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Uniphar alerts:Sign Up Key Stats Today's Range 226▼ 233.6050-Day Range 175▼ 23652-Week Range 163▼ 248Volume141,010 shsAverage Volume33,865 shsMarket Capitalization£712.06 millionP/E Ratio15.91Dividend Yield0.87%Price TargetGBX 310Consensus RatingBuy Company OverviewHeadquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.Read More… Remove Ads Receive UPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Uniphar and its competitors with MarketBeat's FREE daily newsletter. Email Address UPR Stock News HeadlinesUniphar PLC (UPR) Gets a Buy from RBC CapitalMarch 22, 2025 | markets.businessinsider.comUniphar And Two Other Promising Penny Stocks To WatchFebruary 24, 2025 | finance.yahoo.comNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. April 3, 2025 | Porter & Company (Ad)Uncovering Opportunities: 3 Penny Stocks With Market Caps Under US$500MJanuary 22, 2025 | finance.yahoo.comUniphar plc (UPR.IR)October 17, 2024 | finance.yahoo.comUniphar says on track to meet expectations for gross profit for 2024August 1, 2024 | lse.co.ukUniphar ups full-year dividend as profit falls but revenue climbsFebruary 27, 2024 | lse.co.ukUniphar PLC UPRFebruary 17, 2024 | morningstar.comSee More Headlines UPR Stock Analysis - Frequently Asked Questions How have UPR shares performed this year? Uniphar's stock was trading at GBX 170.80 at the start of the year. Since then, UPR stock has increased by 33.9% and is now trading at GBX 228.75. View the best growth stocks for 2025 here. How do I buy shares of Uniphar? Shares of UPR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Uniphar own? Based on aggregate information from My MarketBeat watchlists, some other companies that Uniphar investors own include IXICO (IXI) and ANGLE (AGL). Company Calendar Today4/03/2025Record date for 5/16 Dividend4/24/2025Ex-Dividend for 5/16 Dividend4/24/2025Dividend Payable5/16/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Distribution Sub-IndustryN/A Current SymbolLON:UPR CIKN/A Webwww.uniphar.ie Phone353 1 428 7777FaxN/AEmployees3,000Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 310 High Stock Price TargetGBX 310 Low Stock Price TargetGBX 310 Potential Upside/Downside+35.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 14.38 Trailing P/E Ratio15.91 Forward P/E Ratio12.15 P/E GrowthN/ANet Income£51.04 million Net Margins1.68% Pretax MarginN/A Return on Equity13.18% Return on Assets3.76% Debt Debt-to-Equity Ratio119.48 Current Ratio0.90 Quick Ratio0.60 Sales & Book Value Annual Sales£3.03 billion Price / Sales0.23 Cash FlowGBX 22.96 per share Price / Cash Flow9.97 Book ValueGBX 127.58 per share Price / Book1.79Miscellaneous Outstanding Shares311,281,806Free FloatN/AMarket Cap£712.06 million OptionableNot Optionable Beta0.75 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (LON:UPR) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Uniphar plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Uniphar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.